ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 24.3 | 21.2 | 17.4 |
| Other income | 1.5 | 1.4 | 0.6 |
| Total income | 25.8 | 22.6 | 18.0 |
| Profit before exceptional items & tax | 10.1 | 5.3 | 3.2 |
| Profit before tax | 10.1 | 5.3 | 3.2 |
| Net profit | 7.5 | 3.9 | 4.2 |
| Operating margin | 39.1% | 23.5% | 17.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +78.60% |
|---|---|
| Net profit, quarter on quarter | +92.30% |
| Revenue, year on year | +39.70% |
BSE results filing, BSE: 544353. Figures extracted from the filing.
Amwill Health Care Ltd: key numbers
- Share price
- ₹43.50
- Market cap
- ₹87.02 Cr
- Revenue (annual)
- ₹45.49 Cr
- Net profit (annual)
- ₹11.42 Cr
- P/E (TTM)
- 7.6×Sector 43.8×
- Promoter holding
- 70.65%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amwill Health Care Ltd
All →Amwill Health Care Other Announcement
Amwill Health Care committed ₹3 Crore to Nippon India Credit Opportunities AIF Scheme II. The investment, funded from internal accruals, is drawn down in tranches.
- Value
- ₹3.00 Cr
Amwill Health Care Dividend
Amwill Health Care's board declared an interim dividend of Rs.0.05 per equity share for FY 2026-27 on 23 October 2026. The record date is 30 October 2026 and payment is proposed by 22 November 2026.
Amwill Health Care H1 FY27 Results: Net Profit ₹3.7 Cr, Down 50.7% YoY
Amwill Health Care Ltd reported revenue from operations of ₹22.6 Cr (-7.0% YoY) and net profit of ₹3.7 Cr (-50.7% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.7 Cr · -50.7% YoY
Amwill Health Care Board Meeting Date
Amwill Health Care has scheduled a board meeting for October 23, 2026, to review H1 financial results and consider declaring an interim dividend.
Amwill Health Care Other Announcement
This filing is a standard quarterly Shareholding Pattern submission in accordance with SEBI Regulation 31(1)(b) for Amwill Health Care Ltd as of September 30, 2026.
Amwill Health Care Regulatory Approval
Amwill Health Care received an import license from CDSCO for FoliColor hair products, enabling the company to commence commercial sale and import into India.